TITLE

Linezolid: A Viewpoint by Gary A. Noskin

AUTHOR(S)
Noskin, G.A.
PUB. DATE
April 2000
SOURCE
Drugs;Apr2000, Vol. 59 Issue 4, p828
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on the effectiveness of the linezolid which is a member of a class of antibacterial agents called oxazolidinones. Mechanism of action; Adverse effects.
ACCESSION #
9592784

 

Related Articles

  • Quinolone Molecular Structure-Activity Relationships: What We Have Learned about Improving Antimicrobial Activity. Peterson, Lance R. // Clinical Infectious Diseases;9/15/2001 Supplement 3, Vol. 33, pS180 

    Recently, understanding of how molecular modifications of the core quinolone structure affect(s) antimicrobial agent activity has progressed rapidly. Three positions (2, 3, and 4) cannot be changed without a significant loss of biological activity. Furthermore, it appears that a cyclopropyl...

  • Oral and topical ofloxacin work together on blebitis. Guttman, Cheryl; Cantor, Louis B. // Ophthalmology Times;03/01/2000, Vol. 25 Issue 5, p29 

    Discusses the potential therapeutic effect of topical and oral ofloxacin on bleb-associated infections. Information on blebitis; Mechanism of action of ofloxacin combination regime.

  • Retapamulin: New Topical Antibacterial. Langer, Cheena; Mahajan, Vivek; Gupta, Vipin // JK Science;Oct-Dec2011, Vol. 13 Issue 4, p214 

    The article reviews the Retapamulin, which is a new topical antibacterial.

  • Antibacterial upholstery.  // British Dental Journal;2/26/2011, Vol. 210 Issue 4, p188 

    The article evaluates antibacterial upholstery Plinth 2000.

  • Gemifloxacin. Lowe, M.N.; Lamb, H.M. // Drugs;May2000, Vol. 59 Issue 5, p1137 

    â–´ Gemifloxacin is a fluoroquinolone antibacterial agent which has an enhanced affinity for topoisomerase IV. It has potent activity against most Gram-positive bacteria, particularly Streptococcus pneumoniae. Gemifloxacin is over 30-fold more active than ciprofloxacin and 4- to 8-fold more...

  • Educational approach to reducing unnecessary use of antimicrobials. Chandel, Ritu; Somma, Melissa A. // American Journal of Health-System Pharmacy;12/15/2002, Vol. 59 Issue 24, p2454 

    Describes an educational approach to reducing unnecessary use of antimicrobials at a community physicians' office. Medical personnel involved in the initiative; Proof that treatment for upper-respiratory symptoms other than antimicrobials is acceptable to patients.

  • Antimicrobial resistance and bacterial density. Humphry, R. W.; Gunn, G. J. // Veterinary Record: Journal of the British Veterinary Association;2/22/2014, Vol. 174 Issue 8, p202 

    A letter to the editor is presented in response to the article about the standardization of procedure for testing antimicrobial resistance by the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

  • Minocycline. Allen, James C. // Annals of Internal Medicine;Oct76, Vol. 85 Issue 4, p482 

    Provides information on the antibiotic minocycline. Most important aspect of the pharmacokinetics of minocycline; Background on antimicrobial activity in vitro and in clinical studies; Side effects of vestibular.

  • Antimicrobial stewardship: California and beyond. Trivedi, Kavita K.; Goldstein, Ellie J. C. // Infectious Disease News;May2014, Vol. 27 Issue 5, p34 

    The article focuses on antimicrobial stewardship guidelines in California.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics